Published ahead of print on May 12, 2008, doi:10.1165/rcmb.2008-0059OC
© 2008 American Thoracic Society DOI: 10.1165/rcmb.2008-0059OC Bacterial Peptide Recognition and Immune Activation Facilitated by Human Peptide Transporter PEPT21 Department of Pharmaceutical Sciences, University of Maryland, Baltimore, Maryland; 2 Davis Heart and Lung Research Institute, The Ohio State University, Columbus, Ohio; 3 Nationwide Children's Research Institute, Columbus, Ohio; 4 ACT LLC, Jenkintown, Pennsylvania; and 5 Department of Pharmacology, University of Medicine and Dentistry of New Jersey–Robert Wood Johnson Medical School, Piscataway, New Jersey Correspondence and requests for reprints should be addressed to Daren L. Knoell, Davis Heart and Lung Research Institute, The Ohio State University, 473 W. 12th Ave., Room 405A, Columbus, OH 43210. E-mail: daren.knoell{at}osumc.edu
Microbial detection requires the recognition of pathogen-associated molecular patterns (PAMPs) by pattern recognition receptors (PRRs) that are distributed on the cell surface and within the cytosol. The nucleotide-binding oligomerization domain (NOD)-like receptor (NLR) family functions as an intracellular PRR that triggers the innate immune response. The mechanism by which PAMPs enter the cytosol to interact with NLRs, particularly muropeptides derived from the bacterial proteoglycan cell wall, is poorly understood. PEPT2 is a proton-dependent transporter that mediates the active translocation of di- and tripeptides across epithelial tissues, including the lung. Using computational tools, we initially established that bacterial dipeptides, particularly
Key Words: human lung bacterial cell surface molecules acute phase reactants
This article has been cited by other articles:
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||